AAVogen
Show contact
Expert in commercialization and manufacturing of AAV-based gene therapeutics. 28 years pharma experience and senior leadership (e.g. CEO, Sr. VP) at Shire, AstraZeneca, GSK and Ambrx.
Tom Lloyd
Advisor
Denis Guttridge
Charles Murry
Jeff Chamberlain
Paul Gregorevic
6 members
Current role
Lawson Macartney